Trials / Completed
CompletedNCT02332304
Amniotic Fluid Optical Density Determination as a Test for Assessment of Fetal Lung Maturity.
Amniotic Fluid Optical Density Determination Between 28 and 36 6/7 Weeks of Pregnancy and Its Relationship With the Diagnosis of Neonatal Respiratory Distress Syndrome.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- Saint Thomas Hospital, Panama · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
To determine the relationship between the result of amniotic fluid optical density between 26 and 36 6/7 weeks of pregnancy and the risk of developing neonatal respiratory distress syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Preterm fetus | A sample of amniotic fluid was taken before the birth of fetus between 26 and 36 6/7 weeks of pregnancy. |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2014-11-01
- Completion
- 2014-12-01
- First posted
- 2015-01-06
- Last updated
- 2015-01-06
Locations
1 site across 1 country: Panama
Source: ClinicalTrials.gov record NCT02332304. Inclusion in this directory is not an endorsement.